NO172745C - Analogifremgangsmaate for fremstilling av et herpes simplex viruspolypeptid egnet for anvendelse i en vaksinasjonsprosess - Google Patents

Analogifremgangsmaate for fremstilling av et herpes simplex viruspolypeptid egnet for anvendelse i en vaksinasjonsprosess

Info

Publication number
NO172745C
NO172745C NO84842962A NO842962A NO172745C NO 172745 C NO172745 C NO 172745C NO 84842962 A NO84842962 A NO 84842962A NO 842962 A NO842962 A NO 842962A NO 172745 C NO172745 C NO 172745C
Authority
NO
Norway
Prior art keywords
polypeptime
herp
preparing
simplex virus
analogy procedure
Prior art date
Application number
NO84842962A
Other languages
English (en)
Other versions
NO172745B (no
NO842962L (no
Inventor
Gary H Cohen
Roselyn J Eisenberg
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26996451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO172745(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO842962L publication Critical patent/NO842962L/no
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of NO172745B publication Critical patent/NO172745B/no
Publication of NO172745C publication Critical patent/NO172745C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/224—Herpes related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO84842962A 1982-02-18 1984-07-19 Analogifremgangsmaate for fremstilling av et herpes simplex viruspolypeptid egnet for anvendelse i en vaksinasjonsprosess NO172745C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35002182A 1982-02-18 1982-02-18
US06/463,141 US4762708A (en) 1982-02-18 1983-02-04 Materials and methods for herpes simplex virus vaccination

Publications (3)

Publication Number Publication Date
NO842962L NO842962L (no) 1983-10-17
NO172745B NO172745B (no) 1993-05-24
NO172745C true NO172745C (no) 1993-09-01

Family

ID=26996451

Family Applications (2)

Application Number Title Priority Date Filing Date
NO83833773A NO162366B (no) 1982-02-18 1983-10-17 Fremgangsmaate for isolering av et immunogent preparat av herpes simplex virus type 1 glykoprotein gd-1 eller herpersimplex virus type 2 glykoprotein gd-2 fra en vaeskeproeve.
NO84842962A NO172745C (no) 1982-02-18 1984-07-19 Analogifremgangsmaate for fremstilling av et herpes simplex viruspolypeptid egnet for anvendelse i en vaksinasjonsprosess

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO83833773A NO162366B (no) 1982-02-18 1983-10-17 Fremgangsmaate for isolering av et immunogent preparat av herpes simplex virus type 1 glykoprotein gd-1 eller herpersimplex virus type 2 glykoprotein gd-2 fra en vaeskeproeve.

Country Status (20)

Country Link
US (1) US4762708A (no)
EP (1) EP0101506B1 (no)
JP (3) JP2665332B2 (no)
KR (1) KR910006889B1 (no)
AR (1) AR231496A1 (no)
AT (1) ATE54827T1 (no)
AU (1) AU554710B2 (no)
CA (1) CA1236774A (no)
DE (1) DE3381761D1 (no)
DK (1) DK172619B1 (no)
ES (1) ES8406199A1 (no)
FI (2) FI73885C (no)
GR (1) GR77900B (no)
HU (1) HU195734B (no)
IE (1) IE56479B1 (no)
IL (5) IL80895A (no)
NO (2) NO162366B (no)
NZ (1) NZ220771A (no)
PH (1) PH25689A (no)
WO (1) WO1983002897A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540669A (en) * 1980-09-11 1985-09-10 Merck & Co., Inc. Herpes simplex type I subunit vaccine
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
DE3683688D1 (de) * 1985-04-19 1992-03-12 Wistar Inst Impfstoff fuer die erzeugung einer gegen ein virus schuetzenden immunogenen t-zellen-antwort.
GB8605390D0 (en) * 1986-03-05 1986-04-09 Univ Birmingham Live herpes simplex vaccine
EP0471778A1 (en) * 1989-05-12 1992-02-26 Ciba Corning Diagnostics Corp. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US5654174A (en) * 1995-07-07 1997-08-05 Competitive Technologies, Inc. Herpes simplex virus glycoprotein D variants
US20020090382A1 (en) * 2000-08-01 2002-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Antiviral compounds and methods
US20030219448A1 (en) * 2002-05-24 2003-11-27 Cedars-Sinai Medical Center Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases
DE60324678D1 (de) 2002-07-18 2008-12-24 Univ Washington N t-lymphozyten und damit identifizierte hsv-antigene
US8541002B2 (en) * 2003-09-12 2013-09-24 Agenus Inc. Vaccine for treatment and prevention of herpes simplex virus infection
EP2059255A4 (en) * 2006-09-08 2011-08-31 Univ Pennsylvania VACCINES AGAINST HSV-1 AND HSV-2 AND METHODS OF USE
US8865185B2 (en) * 2006-09-08 2014-10-21 The Trustees Of The University Of Pennsylvania Methods of use for HSV-1 and HSV-2 vaccines
AU2007342345B9 (en) * 2006-12-28 2013-09-12 The Trustees Of The University Of Pennsylvania Herpes Simplex Virus combined subunit vaccines and methods of use thereof
US8057804B2 (en) * 2006-12-28 2011-11-15 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US10478490B2 (en) * 2006-12-28 2019-11-19 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US20130028925A1 (en) * 2006-12-28 2013-01-31 Harvey Friedman Herpes simplex virus combined subunit vaccines and methods of use thereof
US9089537B2 (en) 2010-02-26 2015-07-28 The Trustees Of The University Of Pennslyvania Subunit vaccines for herpes viruses and methods of use
US20140302062A1 (en) * 2011-04-08 2014-10-09 U.S. Army Medical Research And Materiel Command Herpes simplex virus
EP3388835B1 (en) 2012-05-16 2020-04-01 Immune Design Corp. Vaccines for hsv-2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
NO794196L (no) * 1978-12-22 1980-06-24 Biogen Nv Fremgangsmaate ved fremstilling av et rekombinert dna molekyl

Also Published As

Publication number Publication date
ES519875A0 (es) 1984-08-01
AU554710B2 (en) 1986-08-28
FI864102A0 (fi) 1986-10-10
FI833768A (fi) 1983-10-17
IL80896A (en) 1990-02-09
CA1236774A (en) 1988-05-17
EP0101506A4 (en) 1984-07-06
EP0101506B1 (en) 1990-07-25
GR77900B (no) 1984-09-25
JP2567202B2 (ja) 1996-12-25
AR231496A1 (es) 1984-12-28
KR910006889B1 (ko) 1991-09-10
PH25689A (en) 1991-09-04
DK479083D0 (da) 1983-10-17
NO172745B (no) 1993-05-24
JP2665332B2 (ja) 1997-10-22
FI864102A (fi) 1986-10-10
FI73885B (fi) 1987-08-31
EP0101506A1 (en) 1984-02-29
FI73885C (fi) 1987-12-10
DK479083A (da) 1983-10-17
JPH0769924A (ja) 1995-03-14
US4762708A (en) 1988-08-09
IE56479B1 (en) 1991-08-14
IL67930A (en) 1990-02-09
FI833768A0 (fi) 1983-10-17
FI83880B (fi) 1991-05-31
JPH0797396A (ja) 1995-04-11
IL80895A0 (en) 1987-03-31
IL80896A0 (en) 1987-03-31
ATE54827T1 (de) 1990-08-15
IE830332L (en) 1983-08-18
NO162366B (no) 1989-09-11
JP2669594B2 (ja) 1997-10-29
AU1339683A (en) 1983-09-08
ES8406199A1 (es) 1984-08-01
IL67930A0 (en) 1983-06-15
DE3381761D1 (de) 1990-08-30
DK172619B1 (da) 1999-03-01
NO842962L (no) 1983-10-17
NO833773L (no) 1983-10-17
JPS59500216A (ja) 1984-02-16
WO1983002897A1 (en) 1983-09-01
HU195734B (en) 1988-07-28
KR840003420A (ko) 1984-09-08
IL80895A (en) 1990-02-09
NZ220771A (en) 1990-09-26
FI83880C (fi) 1991-09-10

Similar Documents

Publication Publication Date Title
NO172745C (no) Analogifremgangsmaate for fremstilling av et herpes simplex viruspolypeptid egnet for anvendelse i en vaksinasjonsprosess
GB2123694B (en) Hair-setting process
IL70050A0 (en) Opthalmic preparation containing celiprolol and process for the preparation thereof
DE3275904D1 (en) Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
HUT41050A (en) Process for preparing synthetic vaccine against foot-and-mouth disease
DE3260959D1 (en) 3-alkoxypropylene-imino-bis(methylenephosphonic acids) and their salts, process for their preparation and their use
DE3165788D1 (en) Thienopyridinone derivatives, process for their preparation and their therapeutical use
NO172855C (no) Fremgangsmaate for fremstilling av et herpes simplex virusgd glycoprotein
DE3362885D1 (en) Polymerizable, optically active polymer and process for preparing polymerizable polymer
DE3466539D1 (en) 4'-flavonecarboxylic acids, process for their preparation and their therapeutical use
GB2133015B (en) Process for preparing amidoalkanesulfonic acids and their derivatives
DE3063958D1 (en) Process for preparing 4,4'-dinitrostilbene-2,2'-disulfonic acid and its salts and its use
DE3364376D1 (en) Isoindolazines, process for their preparation and their use
DE3260908D1 (en) Process for preparing o,o'-dithiodibenzoic acids
DE3367598D1 (en) 14-amino-steroid derivatives, their therapeutical use and process for their preparation
EP0121081A3 (en) Azolylmethylcycloalkanes, process for their preparation and their therapeutical use
DE3272502D1 (en) A process for preparing an optically active d-alpha-tocopherol and compounds for its preparation
DE3371334D1 (en) Process for the preparation of optically active amines and enamines
YU233783A (en) Process for obtaining alpha-hydroxy-beta-haloethyl-phosphinic acid and salts thereof
ZA831097B (en) Materials and methods for herpes simplex virus vaccination
ZA832069B (en) 7-a-aminoacyl-3-chlorocephalosporins,process for their preparation and their use as medicaments
AU553932B2 (en) Vaccine against herpes virus vaccine
EP0270041A3 (en) Process for preparing 2-chloroethanephosphonic-acid dichlorides
YU238182A (en) Process for preparing 4-thiomethyl-5-methyl-imidazole and acid addition salts thereof
ZA835520B (en) Phosphates,a process for their preparation and their use as pestcombating agents

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2002